Back
Lantheus Holdings Vs. Perspective Therapeutics Industry Stock Comparison
Buy
69
LNTH
Lantheus Holdings
Last Price:
75.51
Seasonality Move:
21.02%
Buy
81
CATX
Perspective Therapeutics
Last Price:
1.81
Seasonality Move:
1.64%
Buy
69
Lantheus Holdings (LNTH)
is a Buy
Is Lantheus Holdings a Buy, Sell or Hold?
- The current Lantheus Holdings [LNTH] share price is $78.18. The Score for LNTH is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- LNTH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
81
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.73. The Score for CATX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
LNTH Stock Price Chart
What is Lantheus Holdings's stock price today?
-
The Lantheus Holdings share price today is $78.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LNTH is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
LNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.66 | Buy |
| Relative Strength Index (14 RSI): | 83.35 | Buy |
| Chaikin Money Flow: | 1913120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.03 - 67.03) | Buy |
| Bollinger Bands (100): | (55.18 - 66.7) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 68.06 | Buy |
| Chaikin Money Flow: | -5156296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.39 - 1.65) | Buy |
| Bollinger Bands (100): | (0.51 - 1.37) | Buy |
LNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.46 | Buy |
| 20-day SMA: | 63.78 | Buy |
| 50-day SMA: | 62.54 | Buy |
| 200-day SMA: | 65.24 | Buy |
| 8-day EMA: | 68.44 | Buy |
| 20-day EMA: | 65.04 | Buy |
| 50-day EMA: | 62.64 | Buy |
| 200-day EMA: | 65.01 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.67 | Buy |
| 20-day SMA: | 1.56 | Buy |
| 50-day SMA: | 1.3 | Buy |
| 200-day SMA: | 0.64 | Buy |
| 8-day EMA: | 1.65 | Buy |
| 20-day EMA: | 1.55 | Buy |
| 50-day EMA: | 1.32 | Buy |
| 200-day EMA: | 0.81 | Buy |
Lantheus Holdings Earnings Growth & LNTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.09 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lantheus Holdings Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||